What is happening with Surface Oncology (SURF) stock?
ST Staff
April 27, 2021
Surface Oncology (SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies and using biological pathways to target the tumor microenvironment, announced the appointment of a new